Target Name: NUDT6
NCBI ID: G11162
Other Name(s): Nucleoside diphosphate-linked moiety X motif 6 (isoform a) | Protein GFG | GFG | bFGF | Nudix hydrolase 6, transcript variant 1 | Nucleoside diphosphate-linked moiety X motif 6 | antisense basic fibroblast growth factor | nudix hydrolase 6 | GFG1 | FGF-AS | Antisense basic fibroblast growth factor | FGF-2 | Nudix motif 6 | FGF2AS | NUDT6_HUMAN | nudix (nucleoside diphosphate linked moiety X)-type motif 6 | NUDT6 variant 1 | GFG-1 | ASFGF2

NUDT6: A Promising Drug Target and Biomarker for Nuclear Membrane Transport

Nucleoside diphosphate-linked moiety X (NUDT6) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. NUDT6 is a key regulator of various cellular processes, including cell signaling, DNA replication, and gene expression. Its functions have been extensively studied, and it has been shown to play a crucial role in various physiological processes.

Recent studies have identified NUDT6 as a promising drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. NUDT6 has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the current understanding of NUDT6, its potential drug target status, and its potential as a biomarker.

Current Understanding of NUDT6

NUDT6 is a non-coding RNA molecule that contains a conserved motif called the nucleoside diphosphate-linked moiety X (NUDT6-X) motif. NUDT6-X is a key regulator of various cellular processes, including cell signaling, DNA replication, and gene expression. It has been shown to play a crucial role in various physiological processes, including cell growth, cell cycle progression, and cell survival.

NUDT6 has been shown to regulate a wide range of gene expression, including the expression of pro-inflammatory genes, cell cycle genes, and stress response genes. It has also been shown to play a role in the regulation of DNA replication and gene expression during the cell cycle.

In addition to its role in cellular processes, NUDT6 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to play a negative role in the regulation of mitochondrial function and to contribute to the negative regulation of cellular signaling pathways, including the TGF-β pathway.

Potential Drug Target Status

NUDT6 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions as a drug target have been shown to include the regulation of cell signaling pathways, cell cycle progression, and DNA replication.

Studies have shown that NUDT6 can be inhibited by small molecules, including inhibitors of the NUDT6-X motif. These inhibitors have been shown to have various therapeutic effects, including the inhibition of cancer cell growth and the inhibition of neurodegenerative disease.

In addition to its potential as a drug target, NUDT6 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions as a biomarker have been shown to include the regulation of cellular processes, including cell growth, cell cycle progression, and gene expression.

Potential as a Biomarker

NUDT6 has been shown to play a role in the regulation of various cellular processes, including cell growth, cell cycle progression, and gene expression. Its functions as a biomarker have been shown to include the regulation of cellular processes, including cell growth, cell cycle progression, and gene expression.

Studies have shown that NUDT6 can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions as a biomarker have been shown to include the regulation of cellular processes, including cell growth, cell cycle progression, and gene expression.

Conclusion

In conclusion, NUDT6 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its functions as a drug target have been shown to include the regulation of cell signaling pathways, cell cycle progression, and DNA replication, as well as its role in the regulation of cellular processes, including

Protein Name: Nudix Hydrolase 6

Functions: May contribute to the regulation of cell proliferation

More Common Targets

NUDT7 | NUDT8 | NUDT9 | NUDT9P1 | NUF2 | NUFIP1 | NUFIP2 | NUGGC | NUMA1 | NUMB | NUMBL | NUP107 | Nup107-160 complex | NUP133 | NUP153 | NUP155 | NUP160 | NUP188 | NUP205 | NUP210 | NUP210L | NUP210P1 | NUP210P2 | NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1